Jean-Michel Dogné

8PUBLICATIONS
10CO-AUTHORS
Toxicology (incl. clinical toxicology)Consumer-oriented product or service developmentPharmaceutical delivery technologiesSoftware quality, processes and metricsAir pollution modelling and control
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Statins Safety Signals: From Precautions to Proportionate Evidence-Based Labeling.

|May 15, 2026
Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications.

|Apr 04, 2026
Differences in Physiologically Based Pharmacokinetic Predictions between Software Platforms Can Be Clinically Relevant: Cases of Levornestrogel and Ethinylestradiol Concentrations with SIMCYP versus PK-Sim from a User Perspective.

Camille Massaux, Jean-Michel Dogné, Flora Tshinanu Musuamba

|Mar 24, 2026
Use of Modeling and Simulation to Inform the Development of Monoclonal Antibodies to Treat Moderate-to-Severe Asthma: A Retrospective Review of EMA Centralized Procedure From 2014 to 2024.

Hélène Haguet, Jean-Michel Dogné, Flora T Musuamba

|Mar 02, 2026
Model informed assessment of QT prolongation during drug development: a five-year retrospective analysis of EMA scientific advices.

Happy Phanio Djokoto, Jean-Michel Dogné, Flora T Musuamba

|Feb 24, 2026
Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 2000 to December 2024.

Grace Shalom Govere, Jean-Michel Dogné, Flora Musuamba

Pageof 2

Frequent Collaborators

5 joint publications

Flora Tshinanu Musuamba

3 joint publications

Jonathan Douxfils

1 joint publications

Charlotte Beaudart

1 joint publications

Grace Shalom Govere